Bliss GVS Pharma Ltd
₹474.85
+22.95
(+5.08%)
as on
Bliss GVS Pharma Stock Performance
as on June 17, 2026 at 9:31 pm IST
Day's Low
Day's High
₹453.00₹477.00
4.60%
Downside
0.45%
Upside
52 Week's Low
52 Week's High
₹118.00₹477.0075.15%
Downside
0.45%
Upside
Bliss GVS Pharma share price movements today
- Previous Close
- ₹451.90
- Open
- ₹456.00
- Volume
- 19.70L
- Upper Circuit
- ₹497.05
- Lower Circuit
- ₹406.75
- Day's Low - High
- ₹453.00 - ₹477.00
- 52 Week Low - High
- ₹118.00 - ₹477.00
Bliss GVS Pharma Historical Returns
- 1 Month Return
- + 57.24 %
- 3 Month Return
- + 114.41 %
- 1 Year Return
- + 218.6 %
- 3 Year Return
- + 451.77 %
- 5 Year Return
- + 308.22 %
Bliss GVS Pharma Fundamentals
as on June 17, 2026 at 4:01 pm IST
Market Cap
₹4,792.68 Cr
Return on Equity (ROE)
6.74
PE Ratio (TTM)
37.41
Return on capital employed (ROCE)
9.16
Industry PE ratio
46.09
Beta (LTM)
1.38
P/B Ratio
1.17
Dividend Yield
0.43
PEG Ratio
9.21
Quarterly Earnings Growth YOY
122.22
EPS (TTM)
8.57
Book Value
99.68
Bliss GVS Pharma Stock Valuation
as on June 17, 2026 at 4:01 pm IST
Bliss GVS Pharma in the last 5 years
Lowest (7.08x)
August 22, 2019
Today (37.41x)
June 16, 2026
Industry (46.09x)
June 16, 2026
Highest (576.11x)
January 3, 2022
Today’s Price to Earnings Ratio: 37.41x
Bliss GVS Pharma Technical Analysis
Track how Bliss GVS Pharma technical analysis has moved over time to understand its trends.
Technicals Summary
Bearish
Neutral
Bullish
Moving Averages
Bearish
Neutral
Bullish
Oscillators
Bearish
Neutral
Bullish
Overall
Oscillators
Name | Value | Action |
|---|---|---|
MACD level (12,26) | 0.83 | Bullish |
CCI (20) | -234.33 | Bullish |
RSI (14) | 64.85 | Neutral |
Momentum (10) | 3.05 | Bullish |
ADI (14) | 22.14 | Neutral |
Ultimate Oscillator (7,14,28) | 88.61 | Bullish |
Moving Averages
Name | Value | Action |
|---|---|---|
SMA (20) | 474.19 | Bullish |
EMA (20) | 474.81 | Bullish |
VWMA (20) | 475.01 | Bullish |
SMA (50) | 473.94 | Bullish |
EMA (50) | 473.86 | Bullish |
SMA (200) | 470.61 | Bullish |
EMA (200) | 470.6 | Bullish |
KAMA (200) | 473.15 | Bullish |
DEMA (200) | 475 | Bullish |
Bliss GVS Pharma Ltd vs Peer Comparison
Compare market cap, revenue, PE, and other key metrics of Bliss GVS Pharma with its industry peers.
Company | Analyst View | Market Cap(in ₹ Cr) | 5 Year CAGR | Debt to Asset Ratio | Net Profit(in ₹ Cr) | Yearly Revenue(in ₹ Cr) |
|---|---|---|---|---|---|---|
| NA | 4,792.68 | 61.64% | 0.56 | 90 | 809 | |
| NA | 0.00 | 29.25% | 0.00 | NA | 15 | |
| NA | 21,257.50 | 25.52% | 0.00 | 115 | 1,716 | |
| NA | 129.46 | -16.15% | 0.59 | 25 | 292 | |
| NA | 0.00 | 12.11% | 0.00 | -5 | 30 |
Bliss GVS Pharma Stock’s Investor Sentiment and Interest
Investment in Bliss GVS Pharma Ltd Shares on INDmoney has grown by 324.46% over the past 30 days, indicating increased transactional activity.
Time period: to
Change:324.46% versus previous 30 day period
Search interest for Bliss GVS Pharma Ltd Stock has decreased by -29% in the last 30 days, reflecting a downward trend in search activity.
Time period: to
Bliss GVS Pharma Ltd Quarterly Profit & Loss
Figures in Rupees Crores
Bliss GVS Pharma Ltd Annual Profit & Loss
Figures in Rupees Crores
Bliss GVS Pharma Ltd Cash Flow
Figures in Rupees Crores
Bliss GVS Pharma Stock Shareholding Pattern
Numbers in percentages
Mutual Funds that own Bliss GVS Pharma Stock
Check out the Mutual Funds with significant holdings in Bliss GVS Pharma.
Funds | Holdings | Shares Held | |
|---|---|---|---|
 Union Active Momentum Fund Direct Growth | 3.11% | 347319 | |
 Bandhan BSE Healthcare Index Fund Direct Growth | 0.13% | 846 | Here |
Bliss GVS Pharma Corporate Actions
View detailed summary of the earnings and dividend history of Bliss GVS Pharma.
Bliss GVS Pharma Ltd Earnings Results
Bliss GVS Pharma Ltd’s net profit jumped 128.96% since last year same period to ₹35.58Cr in the Q4 2025-2026. On a quarterly growth basis, Bliss GVS Pharma Ltd has generated 52.9% jump in its net profits since last 3-months.
Read More about Earnings ResultsBliss GVS Pharma Ltd Dividends February,2026
In the quarter ending December 2025, Bliss GVS Pharma Ltd has declared dividend of ₹0.50 per share on 10 Feb 2026 - translating a dividend yield of 0.22%.
Read More about Dividends
Indices Featuring Bliss GVS Pharma Stock
Check stock indices that include Bliss GVS Pharma.
Insights on Bliss GVS Pharma Ltd
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
POSITIVE IMPACTRevenue Rich
Revenue is up for the last 2 quarters, 236.71 Cr → 268.18 Cr (in ₹), with an average increase of 11.7% per quarter
- POSITIVE IMPACT
Retail Holding Up
Retail Investor have increased holdings from 44.32% to 49.15% in Mar 2026 quarter
- POSITIVE IMPACT
Profit Spike
Netprofit is up for the last 2 quarters, 23.27 Cr → 35.58 Cr (in ₹), with an average increase of 34.6% per quarter
- POSITIVE IMPACT
Best in 1 Year
In the last 1 year, BLISSGVS has outperformed top 5 stocks with highest market-cap in Pharmaceuticals
- POSITIVE IMPACT
Best in 3 Years
In the last 3 years, BLISSGVS has outperformed top 5 stocks with highest market-cap in Pharmaceuticals
- POSITIVE IMPACT
Price Rise
In the last 1 month, BLISSGVS stock has moved up by 57.2%
NO EFFECTPromoter Holding Unchanged
Promoters holdings remained unchanged at 35.36% of holdings in Mar 2026 quarter
NEGATIVE IMPACTFII Holding Down
Foreign Institutions have decreased holdings from 14.54% to 10.45% in Mar 2026 quarter
About Bliss GVS Pharma Ltd
Bliss GVS Pharma has a successful history, with various achievements over the years, such as investment in 51 share capital of Lifeon Labs Pvt Ltd. and the formation of a new company, Asterisk Lifesciences Limited, as a wholly owned foreign subsidiary in the UK for registrations and marketing in Europe. The company has also procured a USD 111.40 million contract from Aon.
To further its growth, Bliss GVS Pharma divested three subsidiaries and one stepdown subsidiary in 2018. The company also invested in a new 200,000 sq. ft. multiproduct facility in Maharashtra, equipped with state-of-the-art process equipment and utilities. In the financial year 2019-2020, the company had 4 wholly owned subsidiaries and 3 stepdown subsidiaries.
Revenue: ₹256.99Cr as on March 2026 (Q4 FY26)
Net Profit: ₹37.00Cr as on March 2026 (Q4 FY26)
Listing date: 26 Jul, 2010
Chairperson Name: Subramanian R Vaidya
| Organisation | Bliss GVS Pharma Ltd |
| Headquarters | Mumbai |
| Industry | Pharmaceuticals |
| CEO | Subramanian R Vaidya |
| E-voting on shares | Click here to vote |
FAQs
What is Bliss GVS Pharma share price today?
Bliss GVS Pharma share price today stands at ₹474.85 as on at the close of the market. Bliss GVS Pharma share today touched a day high of ₹477 and a low of ₹453.
What is the 52 week high and 52 week low range for Bliss GVS Pharma share?
Bliss GVS Pharma touched a 52 week high of ₹477 and a 52 week low of ₹118. Bliss GVS Pharma share price today i.e. is closed at ₹474.85, which is -0.45% down from its 52 week high and 302.42% up from its 52 week low.
What is Bliss GVS Pharma's market capitalisation today?
Bliss GVS Pharma market capitalisation is ₹4,792.68 Cr as on .
How to buy Bliss GVS Pharma shares?
To buy Bliss GVS Pharma shares, you need to follow these steps:
- Open a Demat account and Trading account on INDmoney
- Fund your Trading account
- Search for BLISSGVS or Bliss GVS Pharma Ltd on the INDmoney app to check live prices of the stock
- Click on Buy or SIP to place an order to invest in Bliss GVS Pharma shares. You can invest by selecting the number of shares or set up a fixed SIP to invest every month or week.
What is Bliss GVS Pharma trading volume today?
Bliss GVS Pharma trading volume is 19.70L as on . This means that 19.70L shares of Bliss GVS Pharma were bought and sold on the stock market during today's trading session.